| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 258 | 2025 | 1807 | 22.750 |
Why?
|
| Occupational Diseases | 163 | 2024 | 1458 | 16.170 |
Why?
|
| Asbestos | 55 | 2024 | 251 | 10.840 |
Why?
|
| Lung Neoplasms | 301 | 2024 | 13594 | 9.260 |
Why?
|
| Smoking | 301 | 2024 | 9094 | 8.820 |
Why?
|
| Alcohol Drinking | 166 | 2024 | 4045 | 7.590 |
Why?
|
| Carcinogens | 65 | 2024 | 453 | 7.090 |
Why?
|
| Neoplasms | 256 | 2025 | 22389 | 6.810 |
Why?
|
| Stomach Neoplasms | 70 | 2024 | 1483 | 6.720 |
Why?
|
| Head and Neck Neoplasms | 98 | 2024 | 2931 | 6.510 |
Why?
|
| Case-Control Studies | 547 | 2024 | 22296 | 6.300 |
Why?
|
| Esophageal Neoplasms | 87 | 2024 | 1674 | 6.020 |
Why?
|
| Mesothelioma | 31 | 2020 | 811 | 5.910 |
Why?
|
| Europe | 246 | 2024 | 3441 | 5.260 |
Why?
|
| Lymphoma, Non-Hodgkin | 47 | 2022 | 1376 | 4.990 |
Why?
|
| Risk Factors | 704 | 2024 | 74976 | 4.540 |
Why?
|
| Carcinoma, Squamous Cell | 120 | 2024 | 4064 | 4.310 |
Why?
|
| Diet | 125 | 2024 | 8088 | 3.890 |
Why?
|
| Air Pollutants, Occupational | 33 | 2018 | 406 | 3.660 |
Why?
|
| Environmental Exposure | 75 | 2024 | 4544 | 3.420 |
Why?
|
| Mouth Neoplasms | 50 | 2021 | 597 | 3.370 |
Why?
|
| Tobacco Smoke Pollution | 40 | 2024 | 828 | 3.350 |
Why?
|
| Laryngeal Neoplasms | 42 | 2024 | 514 | 3.300 |
Why?
|
| Hydrocarbons | 20 | 2018 | 105 | 3.260 |
Why?
|
| September 11 Terrorist Attacks | 11 | 2025 | 107 | 3.190 |
Why?
|
| Odds Ratio | 208 | 2024 | 9684 | 3.190 |
Why?
|
| Vehicle Emissions | 21 | 2024 | 651 | 3.140 |
Why?
|
| Tobacco, Smokeless | 20 | 2019 | 133 | 3.130 |
Why?
|
| Italy | 67 | 2024 | 856 | 2.920 |
Why?
|
| Humans | 1380 | 2025 | 768970 | 2.830 |
Why?
|
| Iran | 83 | 2024 | 763 | 2.790 |
Why?
|
| Helicobacter Infections | 15 | 2023 | 390 | 2.750 |
Why?
|
| Incidence | 215 | 2025 | 21547 | 2.720 |
Why?
|
| Male | 950 | 2025 | 365203 | 2.720 |
Why?
|
| Beryllium | 5 | 2024 | 14 | 2.690 |
Why?
|
| Talc | 5 | 2021 | 48 | 2.590 |
Why?
|
| Middle Aged | 749 | 2025 | 223737 | 2.520 |
Why?
|
| Female | 906 | 2025 | 397515 | 2.510 |
Why?
|
| Mortality | 58 | 2024 | 2914 | 2.480 |
Why?
|
| Vegetables | 48 | 2024 | 1199 | 2.450 |
Why?
|
| Urinary Bladder Neoplasms | 59 | 2024 | 2251 | 2.440 |
Why?
|
| Berylliosis | 4 | 2024 | 9 | 2.370 |
Why?
|
| Pleural Neoplasms | 14 | 2019 | 612 | 2.360 |
Why?
|
| Occupations | 43 | 2022 | 516 | 2.360 |
Why?
|
| Aged | 632 | 2025 | 171786 | 2.300 |
Why?
|
| Cohort Studies | 249 | 2024 | 41808 | 2.180 |
Why?
|
| Fruit | 36 | 2024 | 1165 | 2.050 |
Why?
|
| Adult | 618 | 2025 | 223851 | 2.030 |
Why?
|
| Meat | 35 | 2022 | 588 | 2.010 |
Why?
|
| Cause of Death | 64 | 2024 | 3721 | 1.970 |
Why?
|
| Pancreatic Neoplasms | 42 | 2023 | 5443 | 1.960 |
Why?
|
| DNA Adducts | 11 | 2013 | 95 | 1.930 |
Why?
|
| Polymorphism, Genetic | 51 | 2016 | 4251 | 1.910 |
Why?
|
| Mineral Fibers | 12 | 2014 | 26 | 1.890 |
Why?
|
| Colorectal Neoplasms | 38 | 2024 | 6982 | 1.880 |
Why?
|
| Liver Neoplasms | 35 | 2024 | 4363 | 1.830 |
Why?
|
| Risk | 94 | 2023 | 9621 | 1.820 |
Why?
|
| Inhalation Exposure | 18 | 2020 | 432 | 1.770 |
Why?
|
| Adenocarcinoma | 53 | 2024 | 6401 | 1.750 |
Why?
|
| Hodgkin Disease | 23 | 2021 | 1384 | 1.740 |
Why?
|
| Pharyngeal Neoplasms | 28 | 2017 | 113 | 1.730 |
Why?
|
| Genetic Predisposition to Disease | 106 | 2024 | 18068 | 1.700 |
Why?
|
| Asia | 39 | 2024 | 630 | 1.700 |
Why?
|
| Lymphoma | 19 | 2020 | 1900 | 1.680 |
Why?
|
| Mining | 10 | 2020 | 93 | 1.640 |
Why?
|
| Glutathione Transferase | 22 | 2013 | 564 | 1.630 |
Why?
|
| Neoplasms, Second Primary | 22 | 2011 | 1060 | 1.620 |
Why?
|
| Tea | 13 | 2024 | 289 | 1.600 |
Why?
|
| Ethanol | 14 | 2022 | 1331 | 1.590 |
Why?
|
| Social Class | 29 | 2023 | 2009 | 1.530 |
Why?
|
| Life Style | 52 | 2024 | 3931 | 1.530 |
Why?
|
| Risk Assessment | 135 | 2023 | 24333 | 1.510 |
Why?
|
| Helicobacter pylori | 12 | 2022 | 380 | 1.500 |
Why?
|
| Oral Hygiene | 7 | 2021 | 132 | 1.480 |
Why?
|
| Polychlorinated Biphenyls | 4 | 2019 | 235 | 1.470 |
Why?
|
| Hepatitis C | 14 | 2023 | 1595 | 1.470 |
Why?
|
| Logistic Models | 93 | 2024 | 13318 | 1.460 |
Why?
|
| Wood | 12 | 2020 | 95 | 1.460 |
Why?
|
| Fluorocarbons | 4 | 2024 | 506 | 1.450 |
Why?
|
| Opium | 17 | 2024 | 28 | 1.430 |
Why?
|
| Body Mass Index | 66 | 2024 | 13055 | 1.410 |
Why?
|
| Kidney Neoplasms | 42 | 2021 | 4300 | 1.390 |
Why?
|
| Papillomavirus Infections | 15 | 2023 | 1640 | 1.390 |
Why?
|
| Hypopharyngeal Neoplasms | 12 | 2011 | 52 | 1.320 |
Why?
|
| Feeding Behavior | 43 | 2024 | 3205 | 1.290 |
Why?
|
| Uruguay | 69 | 2016 | 104 | 1.280 |
Why?
|
| Carcinoma, Hepatocellular | 23 | 2021 | 2336 | 1.250 |
Why?
|
| Educational Status | 30 | 2023 | 2515 | 1.240 |
Why?
|
| Dust | 15 | 2016 | 488 | 1.230 |
Why?
|
| Coffee | 15 | 2024 | 594 | 1.220 |
Why?
|
| Oropharyngeal Neoplasms | 14 | 2024 | 493 | 1.220 |
Why?
|
| Proportional Hazards Models | 74 | 2024 | 12562 | 1.210 |
Why?
|
| Carcinoma, Small Cell | 15 | 2022 | 419 | 1.200 |
Why?
|
| Colonic Neoplasms | 8 | 2023 | 2543 | 1.180 |
Why?
|
| Leukemia | 20 | 2023 | 1520 | 1.180 |
Why?
|
| Cardiovascular Diseases | 54 | 2024 | 15661 | 1.170 |
Why?
|
| Nasopharyngeal Neoplasms | 4 | 2022 | 290 | 1.140 |
Why?
|
| Epidemiologic Studies | 18 | 2018 | 677 | 1.120 |
Why?
|
| Aged, 80 and over | 211 | 2024 | 59739 | 1.100 |
Why?
|
| Molecular Epidemiology | 10 | 2012 | 473 | 1.080 |
Why?
|
| Breast Neoplasms | 54 | 2024 | 21188 | 1.080 |
Why?
|
| Prevalence | 66 | 2024 | 15879 | 1.070 |
Why?
|
| Plant Extracts | 5 | 2013 | 499 | 1.050 |
Why?
|
| Carcinogens, Environmental | 9 | 2019 | 70 | 1.040 |
Why?
|
| Polymorphism, Single Nucleotide | 63 | 2024 | 16053 | 1.040 |
Why?
|
| Arsenic | 9 | 2022 | 358 | 1.040 |
Why?
|
| Formaldehyde | 5 | 2019 | 361 | 1.040 |
Why?
|
| Drinking | 4 | 2019 | 196 | 1.030 |
Why?
|
| Ascorbic Acid | 8 | 2024 | 658 | 1.030 |
Why?
|
| Herbicides | 8 | 2015 | 104 | 1.030 |
Why?
|
| Ilex paraguariensis | 8 | 2013 | 8 | 1.010 |
Why?
|
| Small Cell Lung Carcinoma | 7 | 2022 | 454 | 0.990 |
Why?
|
| Prospective Studies | 141 | 2024 | 54962 | 0.980 |
Why?
|
| Environmental Pollutants | 12 | 2024 | 1296 | 0.980 |
Why?
|
| Animal Husbandry | 3 | 2014 | 64 | 0.960 |
Why?
|
| DNA Methylation | 16 | 2019 | 4432 | 0.960 |
Why?
|
| Confidence Intervals | 48 | 2019 | 2932 | 0.960 |
Why?
|
| Alcoholic Beverages | 13 | 2018 | 266 | 0.960 |
Why?
|
| Rescue Work | 6 | 2023 | 58 | 0.950 |
Why?
|
| Dietary Fiber | 8 | 2024 | 767 | 0.940 |
Why?
|
| Copper | 4 | 2024 | 369 | 0.920 |
Why?
|
| Minerals | 5 | 2024 | 282 | 0.920 |
Why?
|
| Registries | 51 | 2025 | 8384 | 0.920 |
Why?
|
| Cooking | 10 | 2020 | 327 | 0.900 |
Why?
|
| Sex Factors | 71 | 2021 | 10633 | 0.900 |
Why?
|
| Epidemiologic Methods | 20 | 2014 | 1328 | 0.900 |
Why?
|
| Carcinoma, Renal Cell | 24 | 2013 | 3200 | 0.890 |
Why?
|
| Diet, Mediterranean | 9 | 2023 | 748 | 0.890 |
Why?
|
| Epstein-Barr Virus Infections | 8 | 2023 | 617 | 0.880 |
Why?
|
| Smoke | 8 | 2023 | 242 | 0.880 |
Why?
|
| Cheese | 3 | 2022 | 39 | 0.870 |
Why?
|
| Thyroid Neoplasms | 6 | 2024 | 2360 | 0.870 |
Why?
|
| Livestock | 2 | 2014 | 20 | 0.870 |
Why?
|
| Peritoneal Neoplasms | 6 | 2023 | 714 | 0.870 |
Why?
|
| Coal | 9 | 2014 | 122 | 0.870 |
Why?
|
| Socioeconomic Factors | 48 | 2023 | 7861 | 0.860 |
Why?
|
| Poland | 15 | 2019 | 197 | 0.850 |
Why?
|
| China | 22 | 2024 | 2395 | 0.850 |
Why?
|
| Air Pollution, Indoor | 10 | 2020 | 931 | 0.850 |
Why?
|
| Early Detection of Cancer | 14 | 2024 | 3238 | 0.840 |
Why?
|
| Reproductive History | 10 | 2024 | 210 | 0.840 |
Why?
|
| Lymphoma, B-Cell | 11 | 2017 | 945 | 0.840 |
Why?
|
| Europe, Eastern | 22 | 2012 | 72 | 0.820 |
Why?
|
| Silicosis | 4 | 2020 | 47 | 0.820 |
Why?
|
| Smoking Cessation | 20 | 2019 | 2085 | 0.810 |
Why?
|
| India | 21 | 2017 | 2334 | 0.810 |
Why?
|
| Genome-Wide Association Study | 39 | 2022 | 12801 | 0.800 |
Why?
|
| Air Pollution | 13 | 2024 | 2372 | 0.800 |
Why?
|
| Textiles | 4 | 2019 | 44 | 0.800 |
Why?
|
| New York City | 13 | 2025 | 737 | 0.800 |
Why?
|
| Beverages | 10 | 2013 | 819 | 0.790 |
Why?
|
| Disinfectants | 2 | 2019 | 129 | 0.790 |
Why?
|
| Hepacivirus | 9 | 2023 | 1344 | 0.780 |
Why?
|
| Developing Countries | 13 | 2022 | 2911 | 0.780 |
Why?
|
| Meat-Packing Industry | 4 | 2007 | 12 | 0.770 |
Why?
|
| Multiple Myeloma | 24 | 2020 | 5196 | 0.770 |
Why?
|
| Health Personnel | 8 | 2024 | 3383 | 0.760 |
Why?
|
| Phytoestrogens | 1 | 2021 | 59 | 0.760 |
Why?
|
| Prostatic Neoplasms | 31 | 2021 | 11230 | 0.760 |
Why?
|
| Hepatitis B | 11 | 2013 | 711 | 0.760 |
Why?
|
| Chemical Industry | 13 | 2008 | 115 | 0.760 |
Why?
|
| Genital Neoplasms, Female | 3 | 2024 | 538 | 0.750 |
Why?
|
| Meta-Analysis as Topic | 22 | 2017 | 1364 | 0.750 |
Why?
|
| Industry | 13 | 2012 | 362 | 0.750 |
Why?
|
| Ovarian Cysts | 1 | 2022 | 108 | 0.750 |
Why?
|
| Urban Population | 21 | 2020 | 2046 | 0.740 |
Why?
|
| Time Factors | 71 | 2021 | 40261 | 0.740 |
Why?
|
| Age Distribution | 38 | 2021 | 2875 | 0.740 |
Why?
|
| Obesity | 37 | 2024 | 13091 | 0.740 |
Why?
|
| Volcanic Eruptions | 1 | 2020 | 17 | 0.730 |
Why?
|
| Follow-Up Studies | 85 | 2024 | 39394 | 0.730 |
Why?
|
| Opiate Alkaloids | 4 | 2022 | 27 | 0.720 |
Why?
|
| Cathartics | 1 | 2021 | 129 | 0.720 |
Why?
|
| Alphapapillomavirus | 3 | 2021 | 219 | 0.720 |
Why?
|
| Vinyl Chloride | 5 | 2013 | 15 | 0.720 |
Why?
|
| Age Factors | 65 | 2024 | 18435 | 0.710 |
Why?
|
| Extraction and Processing Industry | 5 | 2016 | 10 | 0.700 |
Why?
|
| Sweden | 22 | 2024 | 1382 | 0.690 |
Why?
|
| Mercury | 8 | 2017 | 289 | 0.680 |
Why?
|
| Nitrosamines | 8 | 2024 | 86 | 0.680 |
Why?
|
| Glycine | 2 | 2021 | 672 | 0.680 |
Why?
|
| Mouthwashes | 3 | 2024 | 57 | 0.680 |
Why?
|
| Silicon Dioxide | 8 | 2024 | 218 | 0.670 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2022 | 301 | 0.670 |
Why?
|
| DNA Repair | 16 | 2013 | 2054 | 0.660 |
Why?
|
| Sex Distribution | 29 | 2017 | 2280 | 0.660 |
Why?
|
| North America | 22 | 2023 | 1290 | 0.650 |
Why?
|
| Oral Health | 7 | 2024 | 493 | 0.650 |
Why?
|
| Data Collection | 9 | 2014 | 3324 | 0.650 |
Why?
|
| Textile Industry | 9 | 2018 | 74 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2014 | 387 | 0.650 |
Why?
|
| Paper | 8 | 2006 | 83 | 0.650 |
Why?
|
| Health Status Disparities | 5 | 2019 | 1886 | 0.640 |
Why?
|
| Styrenes | 5 | 2009 | 23 | 0.640 |
Why?
|
| Construction Materials | 4 | 2016 | 60 | 0.640 |
Why?
|
| Gallbladder Diseases | 2 | 2020 | 139 | 0.640 |
Why?
|
| Prognosis | 61 | 2023 | 30046 | 0.640 |
Why?
|
| Breast Neoplasms, Male | 3 | 2021 | 212 | 0.620 |
Why?
|
| Permethrin | 1 | 2018 | 16 | 0.620 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2011 | 361 | 0.620 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2019 | 465 | 0.620 |
Why?
|
| Residence Characteristics | 8 | 2017 | 2121 | 0.610 |
Why?
|
| Tooth Loss | 6 | 2024 | 200 | 0.610 |
Why?
|
| Benzene | 4 | 2024 | 106 | 0.610 |
Why?
|
| Russia | 12 | 2021 | 386 | 0.600 |
Why?
|
| Hydrocarbons, Chlorinated | 4 | 2007 | 120 | 0.600 |
Why?
|
| Diabetes Mellitus | 17 | 2024 | 5892 | 0.600 |
Why?
|
| Age of Onset | 5 | 2024 | 3346 | 0.600 |
Why?
|
| Environment | 8 | 2019 | 1122 | 0.600 |
Why?
|
| Pesticides | 6 | 2012 | 298 | 0.600 |
Why?
|
| Rectal Neoplasms | 5 | 2023 | 1183 | 0.590 |
Why?
|
| Air Pollutants | 11 | 2024 | 2915 | 0.590 |
Why?
|
| Epidemiologic Research Design | 8 | 2018 | 368 | 0.590 |
Why?
|
| Chloroprene | 4 | 2001 | 5 | 0.590 |
Why?
|
| Insecticides | 3 | 2018 | 200 | 0.580 |
Why?
|
| Tobacco Use Disorder | 5 | 2013 | 708 | 0.570 |
Why?
|
| Asbestos, Serpentine | 1 | 2017 | 24 | 0.570 |
Why?
|
| Antioxidants | 11 | 2024 | 1673 | 0.570 |
Why?
|
| United States | 92 | 2025 | 73186 | 0.570 |
Why?
|
| Endometrial Neoplasms | 5 | 2024 | 1386 | 0.570 |
Why?
|
| Genitalia, Female | 1 | 2018 | 146 | 0.560 |
Why?
|
| Latin America | 16 | 2023 | 416 | 0.560 |
Why?
|
| Gases | 1 | 2018 | 205 | 0.560 |
Why?
|
| Research Design | 18 | 2018 | 6214 | 0.560 |
Why?
|
| Carbon Compounds, Inorganic | 1 | 2016 | 12 | 0.550 |
Why?
|
| Silicon Compounds | 1 | 2016 | 16 | 0.550 |
Why?
|
| Publication Bias | 5 | 2018 | 159 | 0.550 |
Why?
|
| Genotype | 55 | 2017 | 13048 | 0.550 |
Why?
|
| Arylamine N-Acetyltransferase | 8 | 2012 | 87 | 0.550 |
Why?
|
| Motor Vehicles | 4 | 2016 | 280 | 0.550 |
Why?
|
| Food | 11 | 2023 | 768 | 0.540 |
Why?
|
| France | 11 | 2017 | 497 | 0.540 |
Why?
|
| International Agencies | 14 | 2020 | 244 | 0.540 |
Why?
|
| Glycemic Index | 4 | 2020 | 400 | 0.540 |
Why?
|
| Aldehyde Dehydrogenase | 5 | 2012 | 146 | 0.540 |
Why?
|
| Australia | 18 | 2022 | 1265 | 0.530 |
Why?
|
| Gallbladder Neoplasms | 3 | 2024 | 190 | 0.530 |
Why?
|
| Asbestos, Amphibole | 1 | 2016 | 7 | 0.530 |
Why?
|
| Menarche | 5 | 2024 | 538 | 0.530 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2013 | 72 | 0.530 |
Why?
|
| Aging | 11 | 2021 | 8745 | 0.530 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 17 | 2019 | 1642 | 0.530 |
Why?
|
| Overweight | 14 | 2023 | 2448 | 0.520 |
Why?
|
| Carotenoids | 8 | 2018 | 620 | 0.520 |
Why?
|
| Anticarcinogenic Agents | 7 | 2016 | 251 | 0.520 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1197 | 0.510 |
Why?
|
| Folic Acid | 10 | 2024 | 1338 | 0.510 |
Why?
|
| Hepatitis B virus | 7 | 2023 | 533 | 0.510 |
Why?
|
| Ovarian Neoplasms | 13 | 2024 | 4919 | 0.510 |
Why?
|
| Canada | 21 | 2023 | 2130 | 0.510 |
Why?
|
| Survival Rate | 47 | 2024 | 12873 | 0.510 |
Why?
|
| Welding | 3 | 2013 | 89 | 0.510 |
Why?
|
| Population Surveillance | 18 | 2016 | 2597 | 0.500 |
Why?
|
| Health Behavior | 9 | 2020 | 2649 | 0.500 |
Why?
|
| Acrylamide | 2 | 2017 | 59 | 0.500 |
Why?
|
| Rural Population | 16 | 2015 | 2325 | 0.500 |
Why?
|
| Intestinal Neoplasms | 2 | 2022 | 314 | 0.490 |
Why?
|
| Emigrants and Immigrants | 2 | 2024 | 551 | 0.490 |
Why?
|
| Lymphoma, Follicular | 7 | 2022 | 460 | 0.490 |
Why?
|
| Young Adult | 80 | 2024 | 60131 | 0.490 |
Why?
|
| Solvents | 5 | 2010 | 298 | 0.490 |
Why?
|
| Dietary Carbohydrates | 8 | 2015 | 896 | 0.480 |
Why?
|
| Anthropometry | 7 | 2017 | 1345 | 0.480 |
Why?
|
| Meat Products | 10 | 2019 | 97 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2019 | 2812 | 0.480 |
Why?
|
| Romania | 8 | 2016 | 97 | 0.480 |
Why?
|
| Chromosome Aberrations | 5 | 2008 | 1780 | 0.480 |
Why?
|
| Virus Diseases | 2 | 2011 | 724 | 0.470 |
Why?
|
| Hormones | 2 | 2024 | 870 | 0.470 |
Why?
|
| Particulate Matter | 6 | 2024 | 2615 | 0.470 |
Why?
|
| Biliary Tract Neoplasms | 4 | 2023 | 187 | 0.470 |
Why?
|
| Hot Temperature | 6 | 2019 | 1441 | 0.470 |
Why?
|
| Neoplasms, Radiation-Induced | 3 | 2008 | 542 | 0.470 |
Why?
|
| Sunlight | 9 | 2017 | 337 | 0.460 |
Why?
|
| Melanoma | 14 | 2022 | 5709 | 0.460 |
Why?
|
| Polyomavirus Infections | 1 | 2016 | 192 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2018 | 370 | 0.460 |
Why?
|
| Databases, Factual | 20 | 2022 | 8094 | 0.460 |
Why?
|
| RNA, Viral | 3 | 2022 | 2871 | 0.450 |
Why?
|
| Nutritional Status | 10 | 2018 | 1627 | 0.450 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 12 | 2022 | 1437 | 0.450 |
Why?
|
| Dose-Response Relationship, Drug | 31 | 2020 | 10765 | 0.450 |
Why?
|
| Antibodies, Viral | 10 | 2024 | 3215 | 0.440 |
Why?
|
| Purine Nucleosides | 2 | 2011 | 30 | 0.440 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 3 | 2007 | 83 | 0.440 |
Why?
|
| Birth Order | 2 | 2019 | 93 | 0.440 |
Why?
|
| Motor Activity | 8 | 2014 | 2713 | 0.440 |
Why?
|
| Chronic Disease | 14 | 2024 | 9384 | 0.430 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 522 | 0.430 |
Why?
|
| Milk | 5 | 2022 | 438 | 0.430 |
Why?
|
| Atrazine | 1 | 2013 | 9 | 0.430 |
Why?
|
| Adolescent | 86 | 2024 | 89244 | 0.430 |
Why?
|
| Health Surveys | 10 | 2017 | 4055 | 0.430 |
Why?
|
| Poisson Distribution | 15 | 2017 | 508 | 0.430 |
Why?
|
| Dairy Products | 4 | 2022 | 490 | 0.430 |
Why?
|
| Respiratory Tract Diseases | 9 | 2019 | 744 | 0.420 |
Why?
|
| Regression Analysis | 32 | 2022 | 6346 | 0.420 |
Why?
|
| Employment | 3 | 2018 | 1114 | 0.420 |
Why?
|
| Lymphoma, T-Cell | 5 | 2013 | 308 | 0.420 |
Why?
|
| Carcinoma, Transitional Cell | 6 | 2016 | 799 | 0.410 |
Why?
|
| Waist-Hip Ratio | 9 | 2019 | 520 | 0.410 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2006 | 88 | 0.410 |
Why?
|
| Hip Fractures | 6 | 2018 | 997 | 0.400 |
Why?
|
| Internationality | 2 | 2015 | 1008 | 0.400 |
Why?
|
| Glycosyltransferases | 1 | 2013 | 114 | 0.400 |
Why?
|
| Deoxyguanosine | 2 | 2011 | 96 | 0.400 |
Why?
|
| World Health Organization | 13 | 2023 | 1328 | 0.400 |
Why?
|
| Hungary | 7 | 2016 | 82 | 0.400 |
Why?
|
| Enzyme Assays | 1 | 2013 | 103 | 0.400 |
Why?
|
| Paranasal Sinus Neoplasms | 5 | 2002 | 243 | 0.400 |
Why?
|
| Uric Acid | 1 | 2018 | 806 | 0.390 |
Why?
|
| Acetaldehyde | 1 | 2011 | 39 | 0.390 |
Why?
|
| Occupational Health | 7 | 2010 | 812 | 0.390 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 298 | 0.390 |
Why?
|
| Isothiocyanates | 2 | 2002 | 48 | 0.390 |
Why?
|
| Adenoma | 4 | 2023 | 2163 | 0.390 |
Why?
|
| Asbestosis | 4 | 2019 | 81 | 0.390 |
Why?
|
| Czech Republic | 7 | 2016 | 75 | 0.390 |
Why?
|
| Diabetes Complications | 7 | 2019 | 1320 | 0.380 |
Why?
|
| Skin Neoplasms | 15 | 2018 | 5864 | 0.380 |
Why?
|
| Brazil | 11 | 2016 | 1250 | 0.380 |
Why?
|
| Hematocrit | 1 | 2013 | 623 | 0.380 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 936 | 0.380 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2010 | 89 | 0.380 |
Why?
|
| Thailand | 8 | 2015 | 288 | 0.370 |
Why?
|
| Environmental Pollution | 3 | 2004 | 125 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2023 | 12253 | 0.370 |
Why?
|
| Cholangiocarcinoma | 4 | 2022 | 562 | 0.370 |
Why?
|
| Cross-Sectional Studies | 28 | 2024 | 26395 | 0.360 |
Why?
|
| Nuts | 3 | 2018 | 264 | 0.360 |
Why?
|
| Ethylene Oxide | 1 | 2010 | 28 | 0.360 |
Why?
|
| Cardia | 6 | 2015 | 61 | 0.360 |
Why?
|
| Food Preferences | 5 | 2020 | 398 | 0.360 |
Why?
|
| Forecasting | 11 | 2024 | 2945 | 0.360 |
Why?
|
| C-Reactive Protein | 4 | 2014 | 3859 | 0.360 |
Why?
|
| Physical Fitness | 1 | 2015 | 744 | 0.360 |
Why?
|
| Transportation | 1 | 2012 | 217 | 0.360 |
Why?
|
| Bile Ducts, Extrahepatic | 2 | 2022 | 50 | 0.360 |
Why?
|
| Republic of Korea | 7 | 2024 | 592 | 0.360 |
Why?
|
| Water Pollutants, Chemical | 4 | 2020 | 359 | 0.350 |
Why?
|
| Leukocytes | 6 | 2017 | 2034 | 0.350 |
Why?
|
| Bile Duct Neoplasms | 3 | 2022 | 615 | 0.350 |
Why?
|
| Postmenopause | 7 | 2024 | 2519 | 0.350 |
Why?
|
| Cocarcinogenesis | 9 | 2010 | 49 | 0.350 |
Why?
|
| Lipoproteins | 1 | 2015 | 880 | 0.350 |
Why?
|
| European Union | 10 | 2023 | 158 | 0.350 |
Why?
|
| Menopause | 10 | 2024 | 1656 | 0.350 |
Why?
|
| Titanium | 2 | 2004 | 495 | 0.340 |
Why?
|
| Mood Disorders | 1 | 2017 | 1129 | 0.340 |
Why?
|
| Morbidity | 6 | 2019 | 1757 | 0.340 |
Why?
|
| Genes, p53 | 7 | 2011 | 716 | 0.340 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2020 | 957 | 0.340 |
Why?
|
| Environmental Monitoring | 11 | 2017 | 1469 | 0.340 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2022 | 304 | 0.340 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 4 | 2013 | 56 | 0.340 |
Why?
|
| Mutagens | 5 | 2012 | 181 | 0.330 |
Why?
|
| Lymphocytes | 3 | 2008 | 2614 | 0.330 |
Why?
|
| Digestive System Neoplasms | 4 | 2009 | 82 | 0.330 |
Why?
|
| Genetic Variation | 15 | 2016 | 6611 | 0.330 |
Why?
|
| Cotinine | 2 | 2010 | 206 | 0.330 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2018 | 592 | 0.330 |
Why?
|
| Inflammation | 10 | 2024 | 10868 | 0.330 |
Why?
|
| Metals, Heavy | 1 | 2011 | 149 | 0.330 |
Why?
|
| Interviews as Topic | 16 | 2014 | 2744 | 0.330 |
Why?
|
| Agricultural Workers' Diseases | 7 | 2011 | 27 | 0.330 |
Why?
|
| Papillomaviridae | 7 | 2021 | 1140 | 0.320 |
Why?
|
| International Cooperation | 9 | 2012 | 1436 | 0.320 |
Why?
|
| DNA Glycosylases | 3 | 2007 | 125 | 0.320 |
Why?
|
| Genetic Association Studies | 5 | 2016 | 2748 | 0.320 |
Why?
|
| Israel | 14 | 2017 | 726 | 0.320 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2008 | 53 | 0.310 |
Why?
|
| Alcohol-Related Disorders | 2 | 2008 | 243 | 0.310 |
Why?
|
| Acrylonitrile | 2 | 2008 | 19 | 0.310 |
Why?
|
| Iron, Dietary | 3 | 2022 | 148 | 0.310 |
Why?
|
| Hazardous Substances | 7 | 2004 | 153 | 0.310 |
Why?
|
| Chromium | 6 | 2024 | 133 | 0.310 |
Why?
|
| Alcohol Dehydrogenase | 5 | 2012 | 113 | 0.310 |
Why?
|
| Premenopause | 6 | 2024 | 1039 | 0.310 |
Why?
|
| Ultraviolet Rays | 3 | 2013 | 1104 | 0.310 |
Why?
|
| Micronutrients | 1 | 2011 | 390 | 0.310 |
Why?
|
| Genetic Loci | 6 | 2018 | 2630 | 0.310 |
Why?
|
| Diet Surveys | 13 | 2019 | 1160 | 0.310 |
Why?
|
| Waist Circumference | 7 | 2023 | 935 | 0.310 |
Why?
|
| Endotoxins | 2 | 2009 | 520 | 0.300 |
Why?
|
| Breast Feeding | 4 | 2024 | 1364 | 0.300 |
Why?
|
| Vietnam | 4 | 2023 | 415 | 0.300 |
Why?
|
| Causality | 11 | 2012 | 1256 | 0.300 |
Why?
|
| Heating | 3 | 2020 | 104 | 0.300 |
Why?
|
| New York | 5 | 2023 | 884 | 0.290 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 329 | 0.290 |
Why?
|
| Hair Dyes | 4 | 2017 | 30 | 0.290 |
Why?
|
| Germany | 10 | 2024 | 883 | 0.290 |
Why?
|
| X-Rays | 2 | 2006 | 311 | 0.290 |
Why?
|
| Japan | 11 | 2024 | 1418 | 0.290 |
Why?
|
| Styrene | 4 | 2004 | 23 | 0.290 |
Why?
|
| Haplotypes | 14 | 2016 | 2725 | 0.290 |
Why?
|
| Research Report | 1 | 2011 | 369 | 0.290 |
Why?
|
| DNA Damage | 4 | 2013 | 2472 | 0.290 |
Why?
|
| Gastroesophageal Reflux | 4 | 2022 | 836 | 0.290 |
Why?
|
| Obesity, Abdominal | 3 | 2016 | 375 | 0.290 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 7 | 2010 | 276 | 0.290 |
Why?
|
| SEER Program | 7 | 2022 | 1473 | 0.290 |
Why?
|
| Pneumonia | 4 | 2014 | 2164 | 0.280 |
Why?
|
| Diagnostic Errors | 2 | 2014 | 1281 | 0.280 |
Why?
|
| Herpesvirus 4, Human | 4 | 2023 | 1082 | 0.280 |
Why?
|
| Metals | 2 | 2011 | 713 | 0.280 |
Why?
|
| Plastics | 4 | 2011 | 119 | 0.280 |
Why?
|
| Factor Analysis, Statistical | 11 | 2013 | 1002 | 0.280 |
Why?
|
| Multivariate Analysis | 26 | 2019 | 12095 | 0.280 |
Why?
|
| Family Health | 7 | 2017 | 1255 | 0.280 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2024 | 1439 | 0.280 |
Why?
|
| beta Carotene | 6 | 2014 | 523 | 0.280 |
Why?
|
| Food Handling | 2 | 2013 | 158 | 0.270 |
Why?
|
| Carcinoma, Large Cell | 4 | 2020 | 114 | 0.270 |
Why?
|
| Pancreatitis | 3 | 2012 | 1087 | 0.270 |
Why?
|
| Vaccination | 4 | 2022 | 3438 | 0.270 |
Why?
|
| Brassicaceae | 2 | 2007 | 10 | 0.270 |
Why?
|
| Pesticide Residues | 1 | 2007 | 95 | 0.270 |
Why?
|
| Vitamin E | 4 | 2018 | 874 | 0.270 |
Why?
|
| Eating | 5 | 2024 | 1542 | 0.270 |
Why?
|
| Radiation, Ionizing | 4 | 2020 | 252 | 0.270 |
Why?
|
| Reproducibility of Results | 24 | 2024 | 20245 | 0.270 |
Why?
|
| Thinness | 3 | 2022 | 483 | 0.260 |
Why?
|
| Lead | 5 | 2022 | 882 | 0.260 |
Why?
|
| Cytogenetics | 1 | 2006 | 198 | 0.260 |
Why?
|
| Hypertension | 13 | 2019 | 8617 | 0.260 |
Why?
|
| Gastric Mucosa | 3 | 2019 | 602 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 2 | 2019 | 552 | 0.260 |
Why?
|
| False Positive Reactions | 1 | 2008 | 963 | 0.260 |
Why?
|
| Slovakia | 4 | 2012 | 9 | 0.260 |
Why?
|
| Benzo(a)pyrene | 5 | 2011 | 28 | 0.250 |
Why?
|
| Hormone Replacement Therapy | 4 | 2017 | 757 | 0.250 |
Why?
|
| Telomerase | 3 | 2020 | 753 | 0.250 |
Why?
|
| Finland | 8 | 2016 | 609 | 0.250 |
Why?
|
| Pandemics | 3 | 2024 | 8749 | 0.250 |
Why?
|
| Barrett Esophagus | 1 | 2009 | 495 | 0.250 |
Why?
|
| Death Certificates | 5 | 2021 | 172 | 0.250 |
Why?
|
| Epoxide Hydrolases | 3 | 2013 | 122 | 0.250 |
Why?
|
| Volatile Organic Compounds | 2 | 2024 | 86 | 0.240 |
Why?
|
| Medical Record Linkage | 4 | 2011 | 286 | 0.240 |
Why?
|
| 2,4,5-Trichlorophenoxyacetic Acid | 2 | 2015 | 15 | 0.240 |
Why?
|
| BRCA2 Protein | 3 | 2018 | 803 | 0.240 |
Why?
|
| Eggs | 5 | 2017 | 182 | 0.240 |
Why?
|
| Seroepidemiologic Studies | 5 | 2016 | 405 | 0.240 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 2 | 2015 | 25 | 0.240 |
Why?
|
| Family | 4 | 2018 | 3208 | 0.240 |
Why?
|
| Public Health | 5 | 2015 | 2680 | 0.240 |
Why?
|
| Adiposity | 6 | 2023 | 1895 | 0.240 |
Why?
|
| Mass Screening | 9 | 2022 | 5457 | 0.240 |
Why?
|
| Dyslipidemias | 2 | 2017 | 873 | 0.240 |
Why?
|
| Infant | 23 | 2023 | 36556 | 0.240 |
Why?
|
| Coloring Agents | 2 | 2004 | 564 | 0.240 |
Why?
|
| Metallurgy | 8 | 2007 | 90 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2012 | 2848 | 0.240 |
Why?
|
| Parity | 5 | 2024 | 931 | 0.240 |
Why?
|
| New Zealand | 10 | 2016 | 360 | 0.240 |
Why?
|
| Health Status | 6 | 2017 | 4095 | 0.240 |
Why?
|
| Neoplasm Proteins | 7 | 2014 | 3608 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 4 | 2015 | 877 | 0.230 |
Why?
|
| Caprylates | 2 | 2016 | 115 | 0.230 |
Why?
|
| Bayes Theorem | 8 | 2015 | 2360 | 0.230 |
Why?
|
| Liver Cirrhosis | 5 | 2021 | 1962 | 0.230 |
Why?
|
| Dioxins | 4 | 2008 | 91 | 0.230 |
Why?
|
| Pulmonary Emphysema | 3 | 2015 | 689 | 0.230 |
Why?
|
| Respiratory Tract Neoplasms | 4 | 2014 | 56 | 0.230 |
Why?
|
| Lipids | 1 | 2015 | 3345 | 0.220 |
Why?
|
| Gene Frequency | 11 | 2014 | 3626 | 0.220 |
Why?
|
| Yogurt | 2 | 2022 | 71 | 0.220 |
Why?
|
| Chromosomes, Human | 2 | 2017 | 438 | 0.220 |
Why?
|
| Disease Susceptibility | 7 | 2011 | 1794 | 0.220 |
Why?
|
| Chromosome Disorders | 1 | 2006 | 499 | 0.220 |
Why?
|
| Self Report | 7 | 2021 | 3773 | 0.220 |
Why?
|
| Exercise | 11 | 2017 | 5954 | 0.220 |
Why?
|
| Veterinarians | 1 | 2003 | 13 | 0.220 |
Why?
|
| Superoxide Dismutase | 3 | 2013 | 595 | 0.220 |
Why?
|
| Veterinary Medicine | 1 | 2003 | 21 | 0.220 |
Why?
|
| Drug Users | 2 | 2016 | 134 | 0.220 |
Why?
|
| Sarcoidosis | 1 | 2009 | 535 | 0.220 |
Why?
|
| Body Weight | 8 | 2017 | 4628 | 0.220 |
Why?
|
| DNA-Binding Proteins | 8 | 2011 | 9618 | 0.220 |
Why?
|
| Immunologic Surveillance | 1 | 2024 | 93 | 0.220 |
Why?
|
| Nitrates | 2 | 2002 | 260 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2024 | 5434 | 0.220 |
Why?
|
| Sarcoma | 3 | 2022 | 1806 | 0.220 |
Why?
|
| Receptors, Nicotinic | 4 | 2011 | 494 | 0.220 |
Why?
|
| Heart Diseases | 2 | 2015 | 2819 | 0.210 |
Why?
|
| Sewage | 1 | 2023 | 44 | 0.210 |
Why?
|
| Population Groups | 2 | 2021 | 208 | 0.210 |
Why?
|
| Glass | 4 | 2011 | 116 | 0.210 |
Why?
|
| Retrospective Studies | 34 | 2024 | 81903 | 0.210 |
Why?
|
| Sphingomyelins | 1 | 2023 | 105 | 0.210 |
Why?
|
| Laundering | 1 | 2002 | 4 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 11 | 2011 | 1737 | 0.210 |
Why?
|
| Agaricales | 1 | 2023 | 31 | 0.210 |
Why?
|
| Sulfur Dioxide | 2 | 2002 | 178 | 0.210 |
Why?
|
| Hepatitis B, Chronic | 2 | 2021 | 413 | 0.210 |
Why?
|
| Eczema | 1 | 2005 | 245 | 0.210 |
Why?
|
| Animals | 38 | 2022 | 169335 | 0.210 |
Why?
|
| Bronchitis, Chronic | 2 | 2014 | 82 | 0.210 |
Why?
|
| Principal Component Analysis | 10 | 2011 | 948 | 0.210 |
Why?
|
| Agriculture | 4 | 2015 | 187 | 0.200 |
Why?
|
| Acyltransferases | 1 | 2004 | 306 | 0.200 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 1478 | 0.200 |
Why?
|
| Trace Elements | 2 | 2015 | 193 | 0.200 |
Why?
|
| Trichloroethylene | 2 | 2013 | 13 | 0.200 |
Why?
|
| Alleles | 12 | 2015 | 6901 | 0.200 |
Why?
|
| Biomedical Research | 4 | 2018 | 3463 | 0.200 |
Why?
|
| Alkanesulfonic Acids | 2 | 2016 | 203 | 0.200 |
Why?
|
| Nose Neoplasms | 4 | 1999 | 250 | 0.200 |
Why?
|
| Evidence-Based Medicine | 5 | 2016 | 3709 | 0.200 |
Why?
|
| Survivors | 4 | 2015 | 2383 | 0.200 |
Why?
|
| Receptors, Calcitriol | 3 | 2009 | 361 | 0.200 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2001 | 423 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2010 | 1397 | 0.200 |
Why?
|
| Vitamins | 8 | 2015 | 1638 | 0.200 |
Why?
|
| Geography | 5 | 2020 | 654 | 0.200 |
Why?
|
| Garlic | 1 | 2022 | 28 | 0.200 |
Why?
|
| Cost of Illness | 6 | 2017 | 1960 | 0.200 |
Why?
|
| Gastritis, Atrophic | 2 | 2012 | 31 | 0.200 |
Why?
|
| Fabaceae | 4 | 2017 | 103 | 0.200 |
Why?
|
| Maternal Age | 3 | 2018 | 805 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2013 | 313 | 0.200 |
Why?
|
| Cholelithiasis | 1 | 2023 | 408 | 0.200 |
Why?
|
| Human papillomavirus 16 | 3 | 2014 | 268 | 0.200 |
Why?
|
| Dietary Supplements | 4 | 2014 | 3443 | 0.200 |
Why?
|
| Myocardial Ischemia | 3 | 2018 | 2139 | 0.200 |
Why?
|
| Preventive Medicine | 2 | 2019 | 246 | 0.200 |
Why?
|
| Spain | 8 | 2017 | 485 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2015 | 432 | 0.200 |
Why?
|
| Carcinoma | 6 | 2015 | 2340 | 0.190 |
Why?
|
| Butadienes | 2 | 2001 | 107 | 0.190 |
Why?
|
| Gout | 1 | 2009 | 621 | 0.190 |
Why?
|
| Areca | 2 | 2018 | 11 | 0.190 |
Why?
|
| Pentanes | 1 | 2001 | 5 | 0.190 |
Why?
|
| Receptors, Estrogen | 5 | 2016 | 2252 | 0.190 |
Why?
|
| Hemiterpenes | 1 | 2001 | 18 | 0.190 |
Why?
|
| Lead Poisoning | 2 | 2022 | 323 | 0.190 |
Why?
|
| Marital Status | 4 | 2022 | 426 | 0.190 |
Why?
|
| Loss of Heterozygosity | 1 | 2024 | 663 | 0.190 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 1231 | 0.190 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 155 | 0.190 |
Why?
|
| Hydrocarbons, Aromatic | 2 | 2000 | 23 | 0.190 |
Why?
|
| Models, Theoretical | 4 | 2020 | 3580 | 0.190 |
Why?
|
| Choline | 1 | 2023 | 522 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2009 | 1266 | 0.190 |
Why?
|
| Lung | 8 | 2024 | 10099 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 3253 | 0.190 |
Why?
|
| Child | 38 | 2024 | 80960 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 6 | 2013 | 2044 | 0.190 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2015 | 529 | 0.180 |
Why?
|
| Infant, Newborn | 19 | 2021 | 26428 | 0.180 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11932 | 0.180 |
Why?
|
| Paint | 1 | 2020 | 34 | 0.180 |
Why?
|
| Sunburn | 3 | 2013 | 156 | 0.180 |
Why?
|
| Chemoprevention | 3 | 2019 | 326 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 4 | 2016 | 7460 | 0.180 |
Why?
|
| Spouses | 4 | 2016 | 286 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2021 | 1756 | 0.180 |
Why?
|
| Carbon | 4 | 2024 | 672 | 0.180 |
Why?
|
| Nutrition Assessment | 7 | 2016 | 740 | 0.180 |
Why?
|
| Risk Reduction Behavior | 4 | 2017 | 1119 | 0.180 |
Why?
|
| Household Articles | 1 | 2020 | 23 | 0.180 |
Why?
|
| Aluminum | 3 | 2016 | 150 | 0.180 |
Why?
|
| Wine | 7 | 2016 | 172 | 0.180 |
Why?
|
| Aspirin | 4 | 2024 | 3135 | 0.180 |
Why?
|
| Life Expectancy | 3 | 2016 | 1249 | 0.180 |
Why?
|
| Hypersensitivity | 3 | 2015 | 1173 | 0.180 |
Why?
|
| Alcoholism | 3 | 2013 | 1981 | 0.180 |
Why?
|
| Selection Bias | 4 | 2005 | 360 | 0.170 |
Why?
|
| HMGA2 Protein | 1 | 2020 | 101 | 0.170 |
Why?
|
| Telomere | 2 | 2017 | 943 | 0.170 |
Why?
|
| Primary Prevention | 2 | 2019 | 1187 | 0.170 |
Why?
|
| Tumor Virus Infections | 3 | 2016 | 437 | 0.170 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2008 | 930 | 0.170 |
Why?
|
| Women's Health | 7 | 2018 | 2081 | 0.170 |
Why?
|
| Delphi Technique | 1 | 2024 | 890 | 0.170 |
Why?
|
| Healthy Worker Effect | 1 | 1999 | 28 | 0.170 |
Why?
|
| Tuberculosis | 2 | 2015 | 2029 | 0.170 |
Why?
|
| Sex Ratio | 1 | 2020 | 107 | 0.170 |
Why?
|
| Genetic Testing | 4 | 2020 | 3591 | 0.170 |
Why?
|
| Cadmium | 2 | 2011 | 217 | 0.170 |
Why?
|
| Schistosomiasis | 2 | 1998 | 65 | 0.170 |
Why?
|
| Fuel Oils | 2 | 2016 | 36 | 0.170 |
Why?
|
| Argentina | 4 | 2010 | 249 | 0.170 |
Why?
|
| Immunity | 2 | 2022 | 1003 | 0.170 |
Why?
|
| Education | 4 | 2014 | 533 | 0.170 |
Why?
|
| Child, Preschool | 23 | 2021 | 42683 | 0.170 |
Why?
|
| Colonoscopy | 3 | 2023 | 1410 | 0.170 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2017 | 1741 | 0.170 |
Why?
|
| Stroke | 5 | 2019 | 9756 | 0.170 |
Why?
|
| South America | 5 | 2021 | 180 | 0.170 |
Why?
|
| Sarcoma, Kaposi | 6 | 2000 | 375 | 0.170 |
Why?
|
| Nutrition Surveys | 4 | 2023 | 1738 | 0.170 |
Why?
|
| Genome, Human | 6 | 2018 | 4456 | 0.170 |
Why?
|
| Greece | 5 | 2018 | 340 | 0.160 |
Why?
|
| Blood Proteins | 2 | 2002 | 1191 | 0.160 |
Why?
|
| Norway | 5 | 2016 | 501 | 0.160 |
Why?
|
| Body Height | 5 | 2013 | 1569 | 0.160 |
Why?
|
| Occupational Medicine | 1 | 2019 | 116 | 0.160 |
Why?
|
| Models, Statistical | 14 | 2021 | 5110 | 0.160 |
Why?
|
| Vitamin B 6 | 2 | 2010 | 237 | 0.160 |
Why?
|
| Sex Characteristics | 7 | 2019 | 2649 | 0.160 |
Why?
|
| Neoplasm Staging | 13 | 2018 | 11262 | 0.160 |
Why?
|
| Longevity | 4 | 2014 | 1077 | 0.160 |
Why?
|
| Testicular Neoplasms | 3 | 2015 | 808 | 0.160 |
Why?
|
| Dietary Proteins | 4 | 2017 | 960 | 0.160 |
Why?
|
| Nails | 2 | 2018 | 298 | 0.160 |
Why?
|
| Citrus | 1 | 2019 | 49 | 0.160 |
Why?
|
| Sensitivity and Specificity | 11 | 2021 | 14752 | 0.160 |
Why?
|
| Food Industry | 2 | 2013 | 68 | 0.160 |
Why?
|
| Cocaine | 1 | 2024 | 947 | 0.160 |
Why?
|
| Drinking Behavior | 3 | 2012 | 103 | 0.160 |
Why?
|
| Electromagnetic Fields | 2 | 2013 | 289 | 0.150 |
Why?
|
| Environmental Health | 2 | 2019 | 298 | 0.150 |
Why?
|
| Asthma | 8 | 2016 | 6293 | 0.150 |
Why?
|
| Mercury Compounds | 1 | 1998 | 7 | 0.150 |
Why?
|
| Blood Buffy Coat | 1 | 2018 | 10 | 0.150 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2011 | 304 | 0.150 |
Why?
|
| Oxidative Stress | 3 | 2014 | 3139 | 0.150 |
Why?
|
| Marijuana Smoking | 2 | 2013 | 261 | 0.150 |
Why?
|
| Research | 5 | 2017 | 1981 | 0.150 |
Why?
|
| Croatia | 3 | 2016 | 34 | 0.150 |
Why?
|
| Cholecystectomy | 1 | 2020 | 409 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2014 | 1143 | 0.150 |
Why?
|
| Solubility | 1 | 2020 | 1087 | 0.150 |
Why?
|
| Likelihood Functions | 6 | 2014 | 994 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 9 | 2014 | 6086 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2018 | 286 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 20776 | 0.150 |
Why?
|
| Barbering | 2 | 2015 | 12 | 0.140 |
Why?
|
| HLA Antigens | 4 | 2016 | 1336 | 0.140 |
Why?
|
| Polycyclic Compounds | 1 | 1997 | 28 | 0.140 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2019 | 1166 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2021 | 573 | 0.140 |
Why?
|
| Riboflavin | 2 | 2024 | 107 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 1243 | 0.140 |
Why?
|
| Opisthorchiasis | 1 | 1997 | 3 | 0.140 |
Why?
|
| Clonorchiasis | 1 | 1997 | 5 | 0.140 |
Why?
|
| Hypoglycemic Agents | 5 | 2016 | 3110 | 0.140 |
Why?
|
| Pregnancy | 17 | 2024 | 30265 | 0.140 |
Why?
|
| Periodontal Diseases | 1 | 2021 | 455 | 0.140 |
Why?
|
| Nickel | 3 | 2022 | 126 | 0.140 |
Why?
|
| Lymphocytosis | 1 | 2018 | 121 | 0.140 |
Why?
|
| Flavonoids | 1 | 2020 | 447 | 0.140 |
Why?
|
| Cities | 1 | 2020 | 543 | 0.140 |
Why?
|
| Carcinogenicity Tests | 3 | 2012 | 39 | 0.140 |
Why?
|
| Longitudinal Studies | 8 | 2023 | 14794 | 0.140 |
Why?
|
| Rubber | 5 | 2016 | 31 | 0.140 |
Why?
|
| Urban Health | 4 | 2019 | 535 | 0.140 |
Why?
|
| Tongue Neoplasms | 2 | 2013 | 186 | 0.140 |
Why?
|
| Creosote | 1 | 2016 | 3 | 0.140 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7885 | 0.140 |
Why?
|
| Genomics | 5 | 2019 | 5928 | 0.140 |
Why?
|
| Urologic Neoplasms | 2 | 2014 | 318 | 0.140 |
Why?
|
| Survival Analysis | 12 | 2019 | 10115 | 0.140 |
Why?
|
| Iron | 3 | 2022 | 1814 | 0.140 |
Why?
|
| Cooperative Behavior | 3 | 2018 | 1515 | 0.140 |
Why?
|
| Mercury Poisoning | 2 | 1994 | 32 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 1169 | 0.140 |
Why?
|
| Family Characteristics | 2 | 2020 | 1004 | 0.140 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2016 | 1040 | 0.140 |
Why?
|
| Autoimmune Diseases | 2 | 2022 | 2258 | 0.140 |
Why?
|
| Genes, ras | 3 | 2010 | 665 | 0.140 |
Why?
|
| Malondialdehyde | 2 | 2013 | 113 | 0.130 |
Why?
|
| Hepatitis | 2 | 2016 | 228 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2010 | 633 | 0.130 |
Why?
|
| Social Mobility | 1 | 2016 | 30 | 0.130 |
Why?
|
| Fossil Fuels | 2 | 2005 | 53 | 0.130 |
Why?
|
| Platinum | 1 | 1998 | 222 | 0.130 |
Why?
|
| Vitamin D | 5 | 2015 | 3311 | 0.130 |
Why?
|
| Acidosis, Respiratory | 1 | 2016 | 37 | 0.130 |
Why?
|
| Endocrine System Diseases | 1 | 2018 | 250 | 0.130 |
Why?
|
| Nervous System Neoplasms | 2 | 2010 | 91 | 0.130 |
Why?
|
| Guidelines as Topic | 5 | 2014 | 1399 | 0.130 |
Why?
|
| Disease | 3 | 2011 | 673 | 0.130 |
Why?
|
| Denmark | 6 | 2016 | 776 | 0.130 |
Why?
|
| Diphosphonates | 2 | 2018 | 634 | 0.130 |
Why?
|
| Consensus | 2 | 2024 | 3214 | 0.130 |
Why?
|
| HIV Infections | 1 | 2023 | 17591 | 0.130 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11521 | 0.130 |
Why?
|
| Publishing | 3 | 2015 | 837 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2024 | 6547 | 0.130 |
Why?
|
| Hematologic Neoplasms | 3 | 2015 | 1907 | 0.130 |
Why?
|
| Allium | 1 | 2015 | 7 | 0.130 |
Why?
|
| Comorbidity | 12 | 2017 | 10592 | 0.130 |
Why?
|
| Endocrine Disruptors | 2 | 2018 | 265 | 0.130 |
Why?
|
| Receptors, Progesterone | 3 | 2016 | 1159 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2149 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2024 | 4568 | 0.130 |
Why?
|
| Shoes | 1 | 1996 | 92 | 0.130 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 520 | 0.130 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 246 | 0.130 |
Why?
|
| Menstrual Cycle | 2 | 2017 | 546 | 0.130 |
Why?
|
| Proteins | 4 | 2015 | 6011 | 0.130 |
Why?
|
| Pepsinogen C | 2 | 2012 | 7 | 0.130 |
Why?
|
| Scotland | 1 | 2015 | 142 | 0.130 |
Why?
|
| Autopsy | 2 | 2010 | 1013 | 0.130 |
Why?
|
| Africa, Northern | 2 | 2014 | 86 | 0.130 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 1890 | 0.130 |
Why?
|
| Cell Cycle | 4 | 2007 | 2937 | 0.120 |
Why?
|
| Pepsinogen A | 2 | 2012 | 14 | 0.120 |
Why?
|
| Netherlands | 3 | 2017 | 2277 | 0.120 |
Why?
|
| Recreation | 2 | 2011 | 124 | 0.120 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2015 | 27 | 0.120 |
Why?
|
| Rural Health | 3 | 2019 | 302 | 0.120 |
Why?
|
| Size Perception | 1 | 2015 | 32 | 0.120 |
Why?
|
| Amines | 2 | 2022 | 280 | 0.120 |
Why?
|
| Lipid Peroxidation | 3 | 2011 | 276 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2007 | 2350 | 0.120 |
Why?
|
| Eye Neoplasms | 2 | 2007 | 306 | 0.120 |
Why?
|
| Guideline Adherence | 2 | 2015 | 2241 | 0.120 |
Why?
|
| Vitamin B 12 | 2 | 2024 | 529 | 0.120 |
Why?
|
| Selenium | 3 | 2017 | 418 | 0.120 |
Why?
|
| Antibodies | 1 | 2023 | 2422 | 0.120 |
Why?
|
| Cattle | 3 | 2013 | 3819 | 0.120 |
Why?
|
| Isoenzymes | 4 | 2008 | 1687 | 0.120 |
Why?
|
| Public Policy | 2 | 2019 | 552 | 0.120 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2014 | 70 | 0.120 |
Why?
|
| Water Purification | 2 | 2006 | 61 | 0.120 |
Why?
|
| Glottis | 2 | 2007 | 214 | 0.120 |
Why?
|
| Burkitt Lymphoma | 1 | 2017 | 338 | 0.120 |
Why?
|
| Job Description | 2 | 2004 | 61 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2009 | 2542 | 0.120 |
Why?
|
| Ceramics | 2 | 2006 | 113 | 0.110 |
Why?
|
| Self Disclosure | 2 | 2006 | 248 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2014 | 8664 | 0.110 |
Why?
|
| Genes, p16 | 2 | 2012 | 159 | 0.110 |
Why?
|
| Health Promotion | 3 | 2013 | 2210 | 0.110 |
Why?
|
| Lung Diseases | 2 | 2024 | 1944 | 0.110 |
Why?
|
| Pancreatectomy | 1 | 2018 | 825 | 0.110 |
Why?
|
| Commerce | 2 | 2010 | 613 | 0.110 |
Why?
|
| Sodium Chloride | 3 | 2014 | 584 | 0.110 |
Why?
|
| Dietary Fats | 8 | 2009 | 2002 | 0.110 |
Why?
|
| Accidents, Traffic | 2 | 2018 | 819 | 0.110 |
Why?
|
| Sample Size | 2 | 2011 | 848 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 7 | 2020 | 5801 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 4 | 2012 | 2714 | 0.110 |
Why?
|
| Toxicity Tests | 1 | 2014 | 114 | 0.110 |
Why?
|
| Body Size | 2 | 2014 | 463 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2018 | 1363 | 0.110 |
Why?
|
| Nutrition Policy | 2 | 2015 | 467 | 0.110 |
Why?
|
| Heart Failure | 1 | 2018 | 11879 | 0.110 |
Why?
|
| Psoriasis | 1 | 2001 | 926 | 0.110 |
Why?
|
| Water | 1 | 2020 | 1421 | 0.110 |
Why?
|
| Population Dynamics | 2 | 2017 | 314 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2016 | 1151 | 0.110 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 50 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2016 | 365 | 0.110 |
Why?
|
| Immune System Diseases | 1 | 2016 | 253 | 0.110 |
Why?
|
| Skin Pigmentation | 3 | 2013 | 281 | 0.110 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3473 | 0.110 |
Why?
|
| Radon | 2 | 2006 | 91 | 0.110 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
| Genetic Markers | 3 | 2016 | 2604 | 0.110 |
Why?
|
| Epigenomics | 1 | 2019 | 961 | 0.110 |
Why?
|
| Rats | 3 | 2020 | 23786 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 306 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 350 | 0.110 |
Why?
|
| Plants, Toxic | 1 | 1993 | 70 | 0.110 |
Why?
|
| Fishes | 2 | 2013 | 606 | 0.110 |
Why?
|
| Half-Life | 1 | 2014 | 651 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 849 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2019 | 2089 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2019 | 1476 | 0.110 |
Why?
|
| Sheep | 2 | 2012 | 1451 | 0.100 |
Why?
|
| Immunoblotting | 3 | 2007 | 1647 | 0.100 |
Why?
|
| Ovulation Inhibition | 1 | 2012 | 4 | 0.100 |
Why?
|
| DNA, Neoplasm | 3 | 2007 | 1748 | 0.100 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2014 | 125 | 0.100 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 13698 | 0.100 |
Why?
|
| Vaginal Neoplasms | 1 | 2013 | 105 | 0.100 |
Why?
|
| Mastication | 1 | 2012 | 53 | 0.100 |
Why?
|
| Egypt | 7 | 2010 | 100 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 9549 | 0.100 |
Why?
|
| Water Supply | 3 | 2019 | 204 | 0.100 |
Why?
|
| DNA | 5 | 2011 | 7214 | 0.100 |
Why?
|
| Information Storage and Retrieval | 2 | 2016 | 831 | 0.100 |
Why?
|
| Opioid-Related Disorders | 4 | 2014 | 2188 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2019 | 3626 | 0.100 |
Why?
|
| Computer Security | 1 | 2014 | 260 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2017 | 1393 | 0.100 |
Why?
|
| ABO Blood-Group System | 1 | 2015 | 381 | 0.100 |
Why?
|
| American Cancer Society | 2 | 1989 | 69 | 0.100 |
Why?
|
| Genes, BRCA1 | 2 | 2016 | 756 | 0.100 |
Why?
|
| Base Sequence | 3 | 2018 | 12430 | 0.100 |
Why?
|
| Demography | 6 | 2015 | 1642 | 0.100 |
Why?
|
| Ulcer | 1 | 2013 | 203 | 0.100 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 152 | 0.100 |
Why?
|
| Blood Glucose | 6 | 2024 | 6435 | 0.100 |
Why?
|
| Epidemiology | 1 | 1994 | 278 | 0.100 |
Why?
|
| Gastrins | 1 | 2011 | 75 | 0.100 |
Why?
|
| Mutation | 9 | 2020 | 30266 | 0.100 |
Why?
|
| Horses | 1 | 2012 | 296 | 0.100 |
Why?
|
| Gastric Fundus | 1 | 2011 | 37 | 0.100 |
Why?
|
| Porphobilinogen Synthase | 1 | 2011 | 29 | 0.100 |
Why?
|
| Metformin | 2 | 2016 | 909 | 0.100 |
Why?
|
| Penile Neoplasms | 1 | 2013 | 158 | 0.100 |
Why?
|
| Government Programs | 1 | 2014 | 278 | 0.100 |
Why?
|
| Cisplatin | 1 | 1998 | 1661 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 954 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 1156 | 0.090 |
Why?
|
| Australasia | 2 | 2021 | 21 | 0.090 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2011 | 105 | 0.090 |
Why?
|
| Waldenstrom Macroglobulinemia | 2 | 2018 | 1077 | 0.090 |
Why?
|
| Computational Biology | 5 | 2015 | 3562 | 0.090 |
Why?
|
| Health Education | 2 | 2018 | 1059 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2012 | 378 | 0.090 |
Why?
|
| Contraceptives, Oral | 2 | 2015 | 561 | 0.090 |
Why?
|
| Receptors, Steroid | 1 | 2011 | 156 | 0.090 |
Why?
|
| England | 3 | 1997 | 533 | 0.090 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 3 | 2009 | 246 | 0.090 |
Why?
|
| Americas | 4 | 2021 | 110 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3253 | 0.090 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2012 | 190 | 0.090 |
Why?
|
| Genes, BRCA2 | 2 | 2012 | 593 | 0.090 |
Why?
|
| Phenotype | 9 | 2016 | 16731 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 3713 | 0.090 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2012 | 272 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 1 | 2018 | 797 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 507 | 0.090 |
Why?
|
| Ukraine | 2 | 2021 | 151 | 0.090 |
Why?
|
| DNA Repair Enzymes | 4 | 2018 | 346 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 657 | 0.090 |
Why?
|
| Lung Diseases, Obstructive | 3 | 2003 | 311 | 0.090 |
Why?
|
| Analysis of Variance | 5 | 2005 | 6236 | 0.090 |
Why?
|
| DNA Helicases | 2 | 2007 | 854 | 0.090 |
Why?
|
| STAT Transcription Factors | 1 | 2011 | 189 | 0.090 |
Why?
|
| Lactose | 1 | 2010 | 95 | 0.090 |
Why?
|
| Confidentiality | 1 | 2014 | 606 | 0.090 |
Why?
|
| Statistics as Topic | 4 | 2015 | 2360 | 0.090 |
Why?
|
| Chlorophenols | 3 | 1998 | 17 | 0.090 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 985 | 0.090 |
Why?
|
| Lactase | 1 | 2010 | 72 | 0.090 |
Why?
|
| DNA Primers | 1 | 2014 | 2827 | 0.090 |
Why?
|
| Behavior Therapy | 1 | 2016 | 886 | 0.090 |
Why?
|
| Electricity | 1 | 1991 | 177 | 0.090 |
Why?
|
| Power Plants | 1 | 1991 | 125 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1263 | 0.090 |
Why?
|
| Apolipoprotein C-I | 1 | 2009 | 14 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2018 | 737 | 0.090 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2009 | 22 | 0.080 |
Why?
|
| Income | 2 | 2019 | 1879 | 0.080 |
Why?
|
| Lymphotoxin-alpha | 1 | 2010 | 94 | 0.080 |
Why?
|
| Janus Kinases | 1 | 2011 | 253 | 0.080 |
Why?
|
| Ruminants | 2 | 2022 | 4 | 0.080 |
Why?
|
| Gastritis | 1 | 2011 | 199 | 0.080 |
Why?
|
| Tumor Burden | 2 | 2015 | 1913 | 0.080 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 332 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2018 | 2258 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 453 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 411 | 0.080 |
Why?
|
| Codon | 3 | 2011 | 599 | 0.080 |
Why?
|
| Voluntary Health Agencies | 1 | 1989 | 38 | 0.080 |
Why?
|
| Beer | 4 | 2016 | 135 | 0.080 |
Why?
|
| Interpersonal Relations | 2 | 2016 | 1437 | 0.080 |
Why?
|
| Anus Neoplasms | 1 | 2013 | 336 | 0.080 |
Why?
|
| Angiotensinogen | 1 | 2010 | 161 | 0.080 |
Why?
|
| Diet Records | 3 | 2021 | 426 | 0.080 |
Why?
|
| Dental Caries | 1 | 2013 | 429 | 0.080 |
Why?
|
| Engineering | 1 | 2009 | 56 | 0.080 |
Why?
|
| Aflatoxins | 1 | 2008 | 12 | 0.080 |
Why?
|
| Genes, erbB-1 | 1 | 2010 | 163 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 4356 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2024 | 4625 | 0.080 |
Why?
|
| Cadherins | 3 | 2009 | 906 | 0.080 |
Why?
|
| Cytogenetic Analysis | 2 | 2007 | 271 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2022 | 3811 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
| Hospitalization | 5 | 2002 | 10847 | 0.080 |
Why?
|
| Immunization | 1 | 2013 | 1220 | 0.080 |
Why?
|
| Awareness | 1 | 2013 | 653 | 0.080 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 3838 | 0.080 |
Why?
|
| Brain Neoplasms | 4 | 2019 | 9213 | 0.080 |
Why?
|
| Feasibility Studies | 5 | 2016 | 5323 | 0.080 |
Why?
|
| Bulgaria | 2 | 2016 | 17 | 0.080 |
Why?
|
| Knowledge Bases | 1 | 2009 | 97 | 0.080 |
Why?
|
| Paternal Age | 1 | 2009 | 87 | 0.080 |
Why?
|
| Tyrosine | 2 | 2005 | 1427 | 0.080 |
Why?
|
| Carbon Monoxide | 1 | 2012 | 559 | 0.080 |
Why?
|
| Moscow | 2 | 1998 | 6 | 0.080 |
Why?
|
| Interleukin-10 | 3 | 2015 | 1183 | 0.080 |
Why?
|
| Probability | 2 | 2004 | 2483 | 0.080 |
Why?
|
| Food Contamination | 2 | 2008 | 193 | 0.080 |
Why?
|
| Blood Pressure | 4 | 2024 | 8544 | 0.080 |
Why?
|
| Singapore | 3 | 2021 | 299 | 0.080 |
Why?
|
| Vitamin A | 3 | 2000 | 611 | 0.080 |
Why?
|
| Reference Values | 5 | 2013 | 4940 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 2276 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2015 | 542 | 0.080 |
Why?
|
| Amino Acid Substitution | 3 | 2007 | 1742 | 0.080 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2008 | 27 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 567 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2011 | 3232 | 0.080 |
Why?
|
| Disclosure | 2 | 2011 | 755 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2013 | 1526 | 0.080 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2606 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2015 | 23653 | 0.070 |
Why?
|
| Human Genome Project | 2 | 2006 | 202 | 0.070 |
Why?
|
| Uterine Neoplasms | 2 | 2014 | 1424 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2008 | 1536 | 0.070 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2009 | 320 | 0.070 |
Why?
|
| Enzymes | 1 | 2009 | 254 | 0.070 |
Why?
|
| Chi-Square Distribution | 6 | 2013 | 3438 | 0.070 |
Why?
|
| Models, Biological | 5 | 2012 | 9499 | 0.070 |
Why?
|
| Germ-Line Mutation | 3 | 2018 | 1887 | 0.070 |
Why?
|
| Methionine | 1 | 2010 | 573 | 0.070 |
Why?
|
| Swine | 2 | 2012 | 5997 | 0.070 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2012 | 489 | 0.070 |
Why?
|
| Leisure Activities | 1 | 2009 | 310 | 0.070 |
Why?
|
| Wilms Tumor | 1 | 2010 | 378 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2007 | 84 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 5 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2007 | 4 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 267 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2403 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 318 | 0.070 |
Why?
|
| Disabled Persons | 1 | 2017 | 1210 | 0.070 |
Why?
|
| Coal Mining | 1 | 2007 | 12 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 10400 | 0.070 |
Why?
|
| Terminology as Topic | 2 | 2007 | 1541 | 0.070 |
Why?
|
| Checklist | 2 | 2011 | 841 | 0.070 |
Why?
|
| Wales | 2 | 1997 | 87 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 850 | 0.070 |
Why?
|
| Accidents, Occupational | 2 | 2004 | 251 | 0.070 |
Why?
|
| Vitamin D Deficiency | 2 | 2014 | 1388 | 0.070 |
Why?
|
| Linkage Disequilibrium | 4 | 2015 | 2000 | 0.070 |
Why?
|
| Papillomavirus Vaccines | 1 | 2013 | 497 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1064 | 0.070 |
Why?
|
| Workplace | 3 | 2007 | 873 | 0.070 |
Why?
|
| Xenobiotics | 1 | 2007 | 71 | 0.070 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2008 | 218 | 0.070 |
Why?
|
| Knowledge | 1 | 2008 | 178 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 371 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2007 | 292 | 0.070 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2009 | 410 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2010 | 587 | 0.070 |
Why?
|
| Animals, Domestic | 1 | 2006 | 56 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 114 | 0.070 |
Why?
|
| Iron Overload | 1 | 2008 | 246 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2014 | 1068 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 2007 | 322 | 0.070 |
Why?
|
| Keratins | 1 | 2008 | 502 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2020 | 9442 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2012 | 710 | 0.070 |
Why?
|
| Fatty Acids | 2 | 2015 | 1812 | 0.070 |
Why?
|
| Slovenia | 2 | 2007 | 22 | 0.070 |
Why?
|
| Apoptosis | 4 | 2010 | 9527 | 0.070 |
Why?
|
| Jejunal Neoplasms | 1 | 2006 | 20 | 0.070 |
Why?
|
| Ileal Neoplasms | 1 | 2006 | 20 | 0.070 |
Why?
|
| Nicotine | 1 | 2011 | 680 | 0.070 |
Why?
|
| Abdomen | 2 | 2011 | 1137 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1024 | 0.070 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 306 | 0.070 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 734 | 0.070 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2008 | 249 | 0.060 |
Why?
|
| Facility Design and Construction | 2 | 2004 | 85 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 4056 | 0.060 |
Why?
|
| Quebec | 2 | 2006 | 139 | 0.060 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 967 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2009 | 683 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2010 | 519 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2012 | 843 | 0.060 |
Why?
|
| Chickens | 1 | 2007 | 845 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2010 | 1093 | 0.060 |
Why?
|
| Information Services | 1 | 2007 | 239 | 0.060 |
Why?
|
| Models, Genetic | 4 | 2011 | 3449 | 0.060 |
Why?
|
| Sleep | 1 | 2021 | 4820 | 0.060 |
Why?
|
| Linear Models | 5 | 2019 | 5891 | 0.060 |
Why?
|
| Arabs | 2 | 2017 | 190 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2020 | 4040 | 0.060 |
Why?
|
| Pilot Projects | 7 | 2022 | 8748 | 0.060 |
Why?
|
| Duodenal Neoplasms | 1 | 2006 | 114 | 0.060 |
Why?
|
| Germ Cells | 2 | 2022 | 644 | 0.060 |
Why?
|
| Observer Variation | 2 | 2010 | 2623 | 0.060 |
Why?
|
| Pedigree | 5 | 2018 | 4545 | 0.060 |
Why?
|
| Printing | 1 | 2005 | 47 | 0.060 |
Why?
|
| Health Policy | 2 | 2014 | 2700 | 0.060 |
Why?
|
| DNA Modification Methylases | 3 | 2012 | 210 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2015 | 108 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2006 | 158 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2517 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1204 | 0.060 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2006 | 161 | 0.060 |
Why?
|
| Weight Gain | 2 | 2012 | 2359 | 0.060 |
Why?
|
| Random Allocation | 3 | 2013 | 2394 | 0.060 |
Why?
|
| Malaysia | 1 | 2024 | 107 | 0.060 |
Why?
|
| Methylmalonic Acid | 1 | 2024 | 51 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2008 | 943 | 0.060 |
Why?
|
| Leukemia, Lymphoid | 2 | 2016 | 312 | 0.060 |
Why?
|
| Nitrogen | 1 | 2006 | 345 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2011 | 1895 | 0.060 |
Why?
|
| Plants, Edible | 2 | 2003 | 29 | 0.060 |
Why?
|
| Public Opinion | 1 | 2008 | 486 | 0.060 |
Why?
|
| Toxicogenetics | 1 | 2004 | 19 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2007 | 428 | 0.060 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2007 | 329 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2008 | 1885 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2474 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 4528 | 0.060 |
Why?
|
| alpha-Tocopherol | 2 | 2018 | 127 | 0.060 |
Why?
|
| Peroxidase | 2 | 2004 | 610 | 0.060 |
Why?
|
| Herpesvirus 8, Human | 3 | 2000 | 256 | 0.060 |
Why?
|
| Body Weights and Measures | 2 | 2018 | 208 | 0.060 |
Why?
|
| Toothbrushing | 1 | 2024 | 47 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 1461 | 0.050 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 5375 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2019 | 65480 | 0.050 |
Why?
|
| Energy Intake | 5 | 2006 | 2146 | 0.050 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2024 | 118 | 0.050 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2023 | 34 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2015 | 300 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3813 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 1033 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 81 | 0.050 |
Why?
|
| Attitude | 1 | 2008 | 772 | 0.050 |
Why?
|
| Taiwan | 2 | 2015 | 524 | 0.050 |
Why?
|
| Coke | 2 | 2006 | 21 | 0.050 |
Why?
|
| Steel | 2 | 2006 | 27 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2010 | 1095 | 0.050 |
Why?
|
| Gasoline | 2 | 2006 | 49 | 0.050 |
Why?
|
| Tryptophan | 1 | 2005 | 482 | 0.050 |
Why?
|
| Phytosterols | 2 | 2000 | 55 | 0.050 |
Why?
|
| Jews | 3 | 2000 | 359 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2008 | 788 | 0.050 |
Why?
|
| Motivation | 1 | 2013 | 2025 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1891 | 0.050 |
Why?
|
| Habits | 1 | 2003 | 148 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2452 | 0.050 |
Why?
|
| Estrogens | 1 | 2009 | 1536 | 0.050 |
Why?
|
| Heartburn | 1 | 2022 | 71 | 0.050 |
Why?
|
| CpG Islands | 3 | 2013 | 1210 | 0.050 |
Why?
|
| Biometry | 1 | 2006 | 570 | 0.050 |
Why?
|
| Ireland | 2 | 2016 | 170 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2005 | 705 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3629 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2560 | 0.050 |
Why?
|
| Chile | 1 | 2023 | 258 | 0.050 |
Why?
|
| Coronary Disease | 3 | 2013 | 5919 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 1943 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 5804 | 0.050 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2004 | 251 | 0.050 |
Why?
|
| Plant Oils | 1 | 2022 | 199 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2007 | 496 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 4423 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2E1 | 2 | 2015 | 41 | 0.050 |
Why?
|
| B-Lymphocytes | 3 | 2022 | 4794 | 0.050 |
Why?
|
| Georgia | 2 | 2013 | 186 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2024 | 415 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 15471 | 0.050 |
Why?
|
| Occupational Health Services | 1 | 2002 | 149 | 0.050 |
Why?
|
| Occult Blood | 1 | 2022 | 199 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 4413 | 0.050 |
Why?
|
| Arginine | 1 | 2005 | 932 | 0.050 |
Why?
|
| Cystectomy | 2 | 2016 | 645 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2024 | 373 | 0.050 |
Why?
|
| Dermatologic Agents | 1 | 2005 | 313 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 831 | 0.050 |
Why?
|
| Pakistan | 1 | 2002 | 299 | 0.050 |
Why?
|
| Homocysteine | 1 | 2024 | 637 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2005 | 1251 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 1026 | 0.050 |
Why?
|
| Acids | 1 | 2021 | 125 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2001 | 137 | 0.050 |
Why?
|
| Women, Working | 2 | 1999 | 86 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 399 | 0.050 |
Why?
|
| Lactation | 1 | 2003 | 392 | 0.050 |
Why?
|
| Exons | 2 | 2004 | 2395 | 0.040 |
Why?
|
| Kerosene | 1 | 2020 | 15 | 0.040 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 229 | 0.040 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2000 | 26 | 0.040 |
Why?
|
| Poverty | 3 | 1997 | 2720 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2014 | 8055 | 0.040 |
Why?
|
| Biotransformation | 1 | 2000 | 166 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2005 | 606 | 0.040 |
Why?
|
| Aerosols | 2 | 2006 | 636 | 0.040 |
Why?
|
| New South Wales | 1 | 2000 | 69 | 0.040 |
Why?
|
| Cysteine | 1 | 2005 | 897 | 0.040 |
Why?
|
| Genetic Research | 2 | 2011 | 173 | 0.040 |
Why?
|
| Gene Silencing | 3 | 2011 | 1505 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 2001 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2024 | 1209 | 0.040 |
Why?
|
| Biomass | 1 | 2020 | 135 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2009 | 2200 | 0.040 |
Why?
|
| Commonwealth of Independent States | 1 | 1999 | 3 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2007 | 4124 | 0.040 |
Why?
|
| Father-Child Relations | 1 | 2000 | 48 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2004 | 1390 | 0.040 |
Why?
|
| Asbestos, Crocidolite | 1 | 2019 | 18 | 0.040 |
Why?
|
| alpha-Linolenic Acid | 1 | 2000 | 144 | 0.040 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2003 | 392 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 7081 | 0.040 |
Why?
|
| Epigenesis, Genetic | 4 | 2014 | 3836 | 0.040 |
Why?
|
| Hydrochlorothiazide | 1 | 2019 | 95 | 0.040 |
Why?
|
| Hemangiosarcoma | 1 | 2001 | 215 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2024 | 556 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 2442 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2017 | 1820 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1762 | 0.040 |
Why?
|
| Butanones | 1 | 1998 | 23 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2002 | 2226 | 0.040 |
Why?
|
| National Health Programs | 1 | 2002 | 442 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 2000 | 269 | 0.040 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2010 | 223 | 0.040 |
Why?
|
| Metaplasia | 1 | 2019 | 326 | 0.040 |
Why?
|
| Caffeine | 2 | 2015 | 703 | 0.040 |
Why?
|
| Middle East | 1 | 2019 | 233 | 0.040 |
Why?
|
| Scandium | 1 | 2017 | 7 | 0.040 |
Why?
|
| Weight Loss | 1 | 2010 | 2721 | 0.040 |
Why?
|
| Antigens, Bacterial | 2 | 2015 | 1150 | 0.040 |
Why?
|
| Switzerland | 3 | 2015 | 323 | 0.040 |
Why?
|
| Nitroso Compounds | 1 | 1998 | 71 | 0.040 |
Why?
|
| Triglycerides | 2 | 2017 | 2464 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2592 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15951 | 0.040 |
Why?
|
| Acetylene | 1 | 1997 | 8 | 0.040 |
Why?
|
| Bone Density | 1 | 2011 | 3574 | 0.040 |
Why?
|
| Tars | 1 | 1997 | 20 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3447 | 0.040 |
Why?
|
| Alkaloids | 1 | 2019 | 192 | 0.040 |
Why?
|
| Pleural Diseases | 1 | 1998 | 138 | 0.040 |
Why?
|
| Lymphatic Metastasis | 2 | 2013 | 2916 | 0.040 |
Why?
|
| Enalapril | 1 | 2019 | 317 | 0.040 |
Why?
|
| Poultry Products | 1 | 2017 | 10 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2016 | 3554 | 0.040 |
Why?
|
| Tanning | 1 | 1997 | 12 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2002 | 5033 | 0.040 |
Why?
|
| Hazardous Waste | 1 | 1997 | 23 | 0.040 |
Why?
|
| Nutritional Sciences | 2 | 2009 | 148 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3450 | 0.030 |
Why?
|
| Hematologic Tests | 1 | 2018 | 239 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 2893 | 0.030 |
Why?
|
| Exodeoxyribonucleases | 1 | 2018 | 191 | 0.030 |
Why?
|
| Heterozygote | 2 | 2018 | 2798 | 0.030 |
Why?
|
| ROC Curve | 2 | 2015 | 3629 | 0.030 |
Why?
|
| Body Composition | 3 | 2012 | 2462 | 0.030 |
Why?
|
| Albania | 1 | 2016 | 3 | 0.030 |
Why?
|
| Guanine | 1 | 1998 | 280 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2009 | 99 | 0.030 |
Why?
|
| Antigens, Viral | 3 | 2012 | 996 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 395 | 0.030 |
Why?
|
| Nitrogen Compounds | 1 | 1996 | 6 | 0.030 |
Why?
|
| Temperature | 1 | 2003 | 2235 | 0.030 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 2133 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 344 | 0.030 |
Why?
|
| Fertilizers | 1 | 1996 | 24 | 0.030 |
Why?
|
| Portugal | 1 | 2016 | 91 | 0.030 |
Why?
|
| Mice | 2 | 2020 | 82072 | 0.030 |
Why?
|
| Oral Submucous Fibrosis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Male Urogenital Diseases | 1 | 1996 | 48 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 527 | 0.030 |
Why?
|
| Nitrate Reductase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Quality Control | 1 | 1999 | 836 | 0.030 |
Why?
|
| Female Urogenital Diseases | 1 | 1996 | 57 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 370 | 0.030 |
Why?
|
| Austria | 1 | 2016 | 209 | 0.030 |
Why?
|
| Debrisoquin | 1 | 1995 | 6 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2012 | 294 | 0.030 |
Why?
|
| Electronics | 1 | 1997 | 317 | 0.030 |
Why?
|
| Calcium | 2 | 2024 | 5792 | 0.030 |
Why?
|
| Seafood | 2 | 2013 | 395 | 0.030 |
Why?
|
| Coal Tar | 2 | 2006 | 17 | 0.030 |
Why?
|
| Immunotoxins | 1 | 2016 | 175 | 0.030 |
Why?
|
| Chaperonin 60 | 1 | 2015 | 97 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1495 | 0.030 |
Why?
|
| Marriage | 1 | 2017 | 351 | 0.030 |
Why?
|
| Leukoplakia, Oral | 1 | 2015 | 79 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 2911 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 2 | 2016 | 2487 | 0.030 |
Why?
|
| Diabetes Insipidus | 1 | 2015 | 144 | 0.030 |
Why?
|
| Immune System | 2 | 2016 | 800 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 2015 | 224 | 0.030 |
Why?
|
| Oral Ulcer | 1 | 2015 | 96 | 0.030 |
Why?
|
| Physical Chromosome Mapping | 1 | 2015 | 183 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1194 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 1999 | 696 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2003 | 1080 | 0.030 |
Why?
|
| Pulmonary Fibrosis | 1 | 1998 | 506 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18354 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1524 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 686 | 0.030 |
Why?
|
| Osteopontin | 1 | 2016 | 311 | 0.030 |
Why?
|
| Paraquat | 1 | 2014 | 36 | 0.030 |
Why?
|
| Serpins | 1 | 2016 | 246 | 0.030 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 937 | 0.030 |
Why?
|
| Hair | 1 | 2018 | 509 | 0.030 |
Why?
|
| Reproduction | 1 | 2018 | 646 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2016 | 246 | 0.030 |
Why?
|
| Clothing | 1 | 1994 | 96 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1575 | 0.030 |
Why?
|
| Pancreas | 1 | 2021 | 1700 | 0.030 |
Why?
|
| Mouth | 1 | 2016 | 383 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2019 | 625 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 1995 | 265 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 872 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2019 | 631 | 0.030 |
Why?
|
| Developed Countries | 1 | 1997 | 452 | 0.030 |
Why?
|
| Infertility | 1 | 2000 | 655 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 2016 | 244 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2017 | 638 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2002 | 2025 | 0.030 |
Why?
|
| Poultry | 1 | 2013 | 79 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2017 | 823 | 0.030 |
Why?
|
| Organomercury Compounds | 1 | 1993 | 16 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2014 | 2732 | 0.030 |
Why?
|
| Zinc | 1 | 2017 | 677 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 718 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 36854 | 0.030 |
Why?
|
| Dentition | 1 | 2013 | 20 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 382 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 472 | 0.030 |
Why?
|
| Los Angeles | 1 | 2013 | 245 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6569 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2015 | 2508 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2013 | 153 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2067 | 0.030 |
Why?
|
| North Carolina | 1 | 2013 | 329 | 0.030 |
Why?
|
| Sunbathing | 1 | 2013 | 66 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2014 | 296 | 0.030 |
Why?
|
| Reproductive Physiological Phenomena | 1 | 2012 | 4 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4785 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 494 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2005 | 597 | 0.030 |
Why?
|
| Factor VIII | 1 | 2015 | 349 | 0.030 |
Why?
|
| Research Subjects | 1 | 2014 | 249 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 6131 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1998 | 1531 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 13674 | 0.020 |
Why?
|
| Politics | 1 | 1999 | 822 | 0.020 |
Why?
|
| Endosonography | 1 | 2016 | 626 | 0.020 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2016 | 317 | 0.020 |
Why?
|
| Insulin | 2 | 2014 | 6610 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2019 | 972 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2020 | 2771 | 0.020 |
Why?
|
| Biodiversity | 1 | 2015 | 345 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 6856 | 0.020 |
Why?
|
| Colombia | 1 | 2012 | 287 | 0.020 |
Why?
|
| Urothelium | 1 | 2014 | 276 | 0.020 |
Why?
|
| Imidazoles | 1 | 1998 | 1169 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2020 | 1970 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 877 | 0.020 |
Why?
|
| Magnesium | 1 | 2015 | 816 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2013 | 526 | 0.020 |
Why?
|
| Plants, Medicinal | 2 | 2003 | 167 | 0.020 |
Why?
|
| DNA Probes, HPV | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11684 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 2012 | 114 | 0.020 |
Why?
|
| Hepatitis B Vaccines | 1 | 2012 | 178 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 693 | 0.020 |
Why?
|
| Fires | 1 | 2012 | 170 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 2007 | 1629 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2013 | 518 | 0.020 |
Why?
|
| Bangladesh | 1 | 2013 | 742 | 0.020 |
Why?
|
| Metagenome | 1 | 2015 | 465 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 229 | 0.020 |
Why?
|
| Internet | 3 | 2012 | 3112 | 0.020 |
Why?
|
| Safety Management | 1 | 1997 | 765 | 0.020 |
Why?
|
| Hypopharynx | 1 | 2011 | 53 | 0.020 |
Why?
|
| Human papillomavirus 18 | 1 | 2012 | 125 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3810 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 680 | 0.020 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2010 | 17 | 0.020 |
Why?
|
| Oils | 1 | 1991 | 54 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 2173 | 0.020 |
Why?
|
| Hair Color | 1 | 2011 | 131 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2012 | 304 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2012 | 360 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4265 | 0.020 |
Why?
|
| Skin Care | 1 | 2010 | 55 | 0.020 |
Why?
|
| Group III Phospholipases A2 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 492 | 0.020 |
Why?
|
| Volatilization | 2 | 2002 | 76 | 0.020 |
Why?
|
| Fertility | 1 | 1995 | 771 | 0.020 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 3840 | 0.020 |
Why?
|
| Protective Devices | 1 | 2010 | 72 | 0.020 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.020 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Turkmenistan | 1 | 2009 | 3 | 0.020 |
Why?
|
| Stillbirth | 1 | 2013 | 381 | 0.020 |
Why?
|
| Cotton Fiber | 1 | 2009 | 25 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2009 | 48 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2020 | 2936 | 0.020 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2009 | 56 | 0.020 |
Why?
|
| Genetics, Population | 2 | 2005 | 944 | 0.020 |
Why?
|
| Veterans | 2 | 2014 | 2672 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 2403 | 0.020 |
Why?
|
| Dimethylhydrazines | 1 | 1989 | 12 | 0.020 |
Why?
|
| Siberia | 1 | 2009 | 30 | 0.020 |
Why?
|
| Azacitidine | 1 | 2011 | 336 | 0.020 |
Why?
|
| Hospitals, Public | 1 | 2011 | 204 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1994 | 498 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2027 | 0.020 |
Why?
|
| Household Products | 1 | 2009 | 26 | 0.020 |
Why?
|
| Biopsy | 2 | 2013 | 6805 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 911 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 11116 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2011 | 260 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 812 | 0.020 |
Why?
|
| Succinates | 1 | 1989 | 83 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 17173 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4290 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 1998 | 1241 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2008 | 29 | 0.020 |
Why?
|
| Self Concept | 1 | 2015 | 1046 | 0.020 |
Why?
|
| Neck | 1 | 2013 | 736 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1422 | 0.020 |
Why?
|
| Heme | 1 | 2011 | 316 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10486 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 1917 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8559 | 0.020 |
Why?
|
| Infectious Mononucleosis | 1 | 2009 | 133 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1968 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 1669 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2013 | 535 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2013 | 693 | 0.020 |
Why?
|
| Keratin-19 | 1 | 2008 | 33 | 0.020 |
Why?
|
| Thymidylate Synthase | 1 | 2008 | 74 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 245 | 0.020 |
Why?
|
| Seasons | 1 | 2014 | 1524 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 416 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2009 | 767 | 0.020 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 244 | 0.020 |
Why?
|
| Panic Disorder | 1 | 2011 | 613 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 515 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 299 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 828 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2009 | 4032 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1999 | 2528 | 0.020 |
Why?
|
| Esophagus | 1 | 2014 | 1043 | 0.020 |
Why?
|
| Quartz | 1 | 2007 | 23 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2019 | 2192 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 1645 | 0.020 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2007 | 28 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 2763 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2009 | 221 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1990 | 693 | 0.020 |
Why?
|
| Sociology | 1 | 2006 | 21 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 240 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 162 | 0.020 |
Why?
|
| Hospitals | 2 | 2012 | 3904 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1082 | 0.020 |
Why?
|
| Control Groups | 1 | 2006 | 107 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2013 | 1506 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 2004 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 393 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 72 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2010 | 603 | 0.020 |
Why?
|
| Calcium, Dietary | 1 | 2009 | 533 | 0.020 |
Why?
|
| Pyridines | 1 | 1998 | 2895 | 0.020 |
Why?
|
| Emigration and Immigration | 2 | 2000 | 407 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2008 | 472 | 0.020 |
Why?
|
| Religion | 1 | 2009 | 376 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2007 | 245 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2007 | 287 | 0.020 |
Why?
|
| Graphite | 1 | 2006 | 79 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 659 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1996 | 1665 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 1036 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1469 | 0.020 |
Why?
|
| MEDLINE | 1 | 2006 | 119 | 0.020 |
Why?
|
| Butter | 1 | 2005 | 22 | 0.020 |
Why?
|
| Bread | 1 | 2005 | 23 | 0.020 |
Why?
|
| Protein Binding | 1 | 1998 | 9344 | 0.020 |
Why?
|
| Book Industry | 1 | 2005 | 1 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 480 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1608 | 0.020 |
Why?
|
| Glucuronates | 1 | 2005 | 40 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 1841 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2007 | 739 | 0.020 |
Why?
|
| Allergens | 1 | 2013 | 1444 | 0.020 |
Why?
|
| Rectum | 1 | 2010 | 900 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 763 | 0.020 |
Why?
|
| Schools | 1 | 2014 | 1498 | 0.020 |
Why?
|
| Pyrenes | 1 | 2005 | 51 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2015 | 2701 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 1056 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 2666 | 0.020 |
Why?
|
| Threshold Limit Values | 1 | 2004 | 12 | 0.020 |
Why?
|
| Military Personnel | 1 | 2014 | 1264 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2831 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 27 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2016 | 3143 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2011 | 1341 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 2204 | 0.010 |
Why?
|
| Codeine | 1 | 2004 | 52 | 0.010 |
Why?
|
| Cyclins | 1 | 2006 | 606 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 12174 | 0.010 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2004 | 95 | 0.010 |
Why?
|
| Hygiene | 1 | 2004 | 95 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2010 | 2205 | 0.010 |
Why?
|
| Meningioma | 1 | 2012 | 1226 | 0.010 |
Why?
|
| Contrast Media | 1 | 2017 | 5334 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2003 | 106 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2565 | 0.010 |
Why?
|
| Malnutrition | 1 | 2009 | 632 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1498 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3723 | 0.010 |
Why?
|
| Korea | 1 | 2002 | 97 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 2002 | 46 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1780 | 0.010 |
Why?
|
| Physical Examination | 1 | 2008 | 1262 | 0.010 |
Why?
|
| Sampling Studies | 2 | 1998 | 615 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2006 | 794 | 0.010 |
Why?
|
| Dental Amalgam | 1 | 2002 | 65 | 0.010 |
Why?
|
| Sinusitis | 1 | 2011 | 998 | 0.010 |
Why?
|
| Point Mutation | 1 | 2007 | 1596 | 0.010 |
Why?
|
| Walking | 1 | 2009 | 1201 | 0.010 |
Why?
|
| Colon | 1 | 2010 | 1803 | 0.010 |
Why?
|
| USSR | 1 | 2001 | 19 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2007 | 565 | 0.010 |
Why?
|
| Time | 1 | 2003 | 552 | 0.010 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 301 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6291 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4541 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1340 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.010 |
Why?
|
| Inpatients | 1 | 2012 | 2569 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 816 | 0.010 |
Why?
|
| Morphine | 1 | 2004 | 658 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 3116 | 0.010 |
Why?
|
| Armenia | 1 | 1999 | 16 | 0.010 |
Why?
|
| Mental Recall | 1 | 2006 | 1226 | 0.010 |
Why?
|
| Sex | 1 | 1999 | 53 | 0.010 |
Why?
|
| Suicide | 2 | 2004 | 1606 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2000 | 210 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5216 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 11886 | 0.010 |
Why?
|
| Nervous System | 1 | 2002 | 546 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2005 | 1758 | 0.010 |
Why?
|
| Medicare | 1 | 2016 | 6888 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1998 | 354 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 726 | 0.010 |
Why?
|
| Dietary Sucrose | 1 | 1999 | 242 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1998 | 646 | 0.010 |
Why?
|
| Glioma | 1 | 2012 | 3532 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2002 | 1970 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15604 | 0.010 |
Why?
|
| DDT | 1 | 1996 | 32 | 0.010 |
Why?
|
| Mental Health | 1 | 2011 | 3275 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 7578 | 0.010 |
Why?
|
| Skin | 1 | 2010 | 4506 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1996 | 6876 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2001 | 2342 | 0.010 |
Why?
|
| Glutathione | 1 | 1999 | 589 | 0.010 |
Why?
|
| Paris | 1 | 1995 | 41 | 0.010 |
Why?
|
| Transients and Migrants | 1 | 1999 | 170 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 7603 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1996 | 128 | 0.010 |
Why?
|
| Quality of Life | 1 | 2017 | 13510 | 0.010 |
Why?
|
| Schistosomiasis haematobia | 1 | 1994 | 16 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2002 | 841 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 2960 | 0.010 |
Why?
|
| Zimbabwe | 1 | 1994 | 135 | 0.010 |
Why?
|
| Telephone | 1 | 1998 | 630 | 0.010 |
Why?
|
| Stem Cells | 1 | 2007 | 3539 | 0.010 |
Why?
|
| Workers' Compensation | 1 | 1994 | 150 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2905 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 1999 | 806 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2011 | 4640 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 3780 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 9080 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 1904 | 0.010 |
Why?
|
| Depression | 1 | 2011 | 8231 | 0.010 |
Why?
|
| Unemployment | 1 | 1993 | 211 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2009 | 6987 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14201 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1999 | 2100 | 0.000 |
Why?
|
| Kidney | 1 | 2002 | 7058 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1998 | 12806 | 0.000 |
Why?
|
| Parents | 1 | 1994 | 3597 | 0.000 |
Why?
|